208 related articles for article (PubMed ID: 31016515)
1. HDAC-selective Inhibitor Cay10603 Has Single Anti-tumour Effect in Burkitt's Lymphoma Cells by Impeding the Cell Cycle.
Ma XJ; Xu G; Li ZJ; Chen F; Wu D; Miao JN; Zhan Y; Fan Y
Curr Med Sci; 2019 Apr; 39(2):228-236. PubMed ID: 31016515
[TBL] [Abstract][Full Text] [Related]
2. HDAC6 promotes cell proliferation and confers resistance to gefitinib in lung adenocarcinoma.
Wang Z; Tang F; Hu P; Wang Y; Gong J; Sun S; Xie C
Oncol Rep; 2016 Jul; 36(1):589-97. PubMed ID: 27221381
[TBL] [Abstract][Full Text] [Related]
3. β-elemene against Burkitt's lymphoma via activation of PUMA mediated apoptotic pathway.
Hu T; Gao Y
Biomed Pharmacother; 2018 Oct; 106():1557-1562. PubMed ID: 30119230
[TBL] [Abstract][Full Text] [Related]
4. [Effects of mTOR Inhibitor Rapamycin on Burkitt's Lymphoma Cells].
Zhou LH; Zhu XP; Xiao HF; Xin PL; Li CT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1397-1405. PubMed ID: 29070114
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Antiproliferative and Pro-Apoptotic Effects of Nitrostyrenes and Related Compounds in Burkitt's Lymphoma.
Byrne AJ; Bright SA; Fayne D; McKeown JP; McCabe T; Twamley B; Williams C; Meegan MJ
Med Chem; 2018 Feb; 14(2):181-199. PubMed ID: 28969575
[TBL] [Abstract][Full Text] [Related]
6. Identification of HDAC6-Selective Inhibitors of Low Cancer Cell Cytotoxicity.
Gaisina IN; Tueckmantel W; Ugolkov A; Shen S; Hoffen J; Dubrovskyi O; Mazar A; Schoon RA; Billadeau D; Kozikowski AP
ChemMedChem; 2016 Jan; 11(1):81-92. PubMed ID: 26592932
[TBL] [Abstract][Full Text] [Related]
7. Ouabain induces apoptosis and autophagy in Burkitt's lymphoma Raji cells.
Meng L; Wen Y; Zhou M; Li J; Wang T; Xu P; Ouyang J
Biomed Pharmacother; 2016 Dec; 84():1841-1848. PubMed ID: 27894666
[TBL] [Abstract][Full Text] [Related]
8. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase 6 activity is critical for the metastasis of Burkitt's lymphoma cells.
Ding N; Ping L; Feng L; Zheng X; Song Y; Zhu J
Cancer Cell Int; 2014; 14(1):139. PubMed ID: 25546298
[TBL] [Abstract][Full Text] [Related]
10. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.
Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL
Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938
[TBL] [Abstract][Full Text] [Related]
12. Effect of trichostatin A on Burkitt's lymphoma cells: Inhibition of EPS8 activity through Phospho-Erk1/2 pathway.
Sun P; Zhou X; He Y; Liu H; Wang Y; Chen Y; Li M; He Y; Li G; Li Y
Biochem Biophys Res Commun; 2018 Mar; 497(4):990-996. PubMed ID: 29462617
[TBL] [Abstract][Full Text] [Related]
13. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
[TBL] [Abstract][Full Text] [Related]
14. Effects of digoxin on cell cycle, apoptosis and NF-κB pathway in Burkitt's lymphoma cells and animal model.
Wang T; Xu P; Wang F; Zhou D; Wang R; Meng L; Wang X; Zhou M; Chen B; Ouyang J
Leuk Lymphoma; 2017 Jul; 58(7):1673-1685. PubMed ID: 28084852
[TBL] [Abstract][Full Text] [Related]
15. OBP‑801, a novel histone deacetylase inhibitor, induces M‑phase arrest and apoptosis in rhabdomyosarcoma cells.
Tomoyasu C; Kikuchi K; Kaneda D; Yagyu S; Miyachi M; Tsuchiya K; Iehara T; Sakai T; Hosoi H
Oncol Rep; 2019 Jan; 41(1):643-649. PubMed ID: 30365145
[TBL] [Abstract][Full Text] [Related]
16. New Disubstituted Quindoline Derivatives Inhibiting Burkitt's Lymphoma Cell Proliferation by Impeding c-MYC Transcription.
Liu HY; Chen AC; Yin QK; Li Z; Huang SM; Du G; He JH; Zan LP; Wang SK; Xu YH; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
J Med Chem; 2017 Jul; 60(13):5438-5454. PubMed ID: 28603988
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents.
Xie R; Li Y; Tang P; Yuan Q
Eur J Med Chem; 2018 Jan; 143():320-333. PubMed ID: 29202397
[TBL] [Abstract][Full Text] [Related]
18. Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3β by increased SIRT3 expression.
Kong J; Wang L; Ren L; Yan Y; Cheng Y; Huang Z; Shen F
Toxicol Appl Pharmacol; 2018 Mar; 342():1-13. PubMed ID: 29407771
[TBL] [Abstract][Full Text] [Related]
19. Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt's Lymphoma.
Wang N; Zeng GZ; Yin JL; Bian ZX
Biochem Biophys Res Commun; 2019 Nov; 519(3):533-539. PubMed ID: 31537387
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor.
North BJ; Almeciga-Pinto I; Tamang D; Yang M; Jones SS; Quayle SN
PLoS One; 2017; 12(3):e0173507. PubMed ID: 28264055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]